Amplia Therapeutics @ampliatx
Amplia Therapeutics Limited (ASX:ATX) is a Melbourne-based biopharmaceutical company focused on the clinical development of novel oncology drugs. ampliatx.com Melbourne, Victoria Joined October 2016-
Tweets257
-
Followers309
-
Following57
-
Likes35
$ATX | Amplia has today released its Quarterly Activities and Cash Flow Report for the quarter ended 31 March 2024. See today’s ASX release: bit.ly/ATX-Quarterly-… #ASX #research #innovation #cancerresearch #pancreaticcancer #clinicaltrial
CAPITAL RAISE | #Amplia (ASX:ATX) has today announced it is undertaking a fully underwritten Entitlement Offer to eligible shareholders to raise $4.27m. Read today’s ASX release: bit.ly/ATX-Entitlemen… $ATX #pharma #biotech #pancreaticcancer #clinicaltrial #ovariancancer #cancer
$ATX | #Amplia is pleased to announce that data from our Phase 1b ACCENT trial in pancreatic cancer has been presented at the prestigious American Association of Cancer Research (AACR) annual meeting in San Diego. Read the ASX release: bit.ly/ATX-AACR-Poste…
LET'S CONNECT ▸ Over the coming months, #Amplia representatives will be at key conferences and scientific meetings across the globe. We welcome the opportunity to connect with potential partners, investors, and collaborators interested in learning more about our programs.
$ATX | In this video, #Amplia CEO & MD, Dr Chris Burns, explains the promising early results from the Phase 1b portion of the ACCENT trial, and recruitment progress for the Phase 2a portion of trial across Australia and Korea. Watch the video: youtu.be/KAZ3y-I4wNk
$ATX | #Amplia has today released an update on the ACCENT trial in pancreatic cancer. Recruitment for the Phase 2a stage of the trial is progressing well, with 11 patients currently enrolled in the cohort. Read today’s ASX release: bit.ly/ATX-ACCENT-Upd… #pancreaticcancer
$ATX | Did you know that around 1,815 Australians are diagnosed with #ovariancancer each year? Recent preclinical data revealed exciting potential for #Amplia's investigational drug, narmafotinib, highlighting a promising new approach for patients with limited treatment options.
$ATX | #Amplia CEO & MD, Dr Chris Burns spoke with @proactive_au about the Company’s latest developments, including progress on the ACCENT trial, including trial sites in Korea, and recent FDA clearance to run a trial of narmafotinib in the USA. bit.ly/ATX-Proactive-…
We are honoured to support the #LunchByTheYarra and vital work of the Jreissati Pancreatic Cancer Centre at #Epworth - a recruiting site for our Phase II ACCENT Clinical Trial, and valued innovators in patient care. Learn more 👉 lnkd.in/gitwSb39 #ATX #pancreaticcancer
Today, on World Cancer Day, we would like to thank our ACCENT trial collaborators and partners for bringing hope to pancreatic cancer patients. Learn more: bit.ly/ATX-ACCENT-Rec… $ATX #Amplia #cancer #biotech #innovation #pancreaticcancer #WorldCancerDay
We would like to congratulate @ProfGLongMIA and @ProfRScolyerMIA on being named Australians of the Year. We applaud their advocacy for clinical trial participation, which has the potential improve #cancer treatments for all. bit.ly/ATX-AOY
Today's announcement - that the US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the US - has been shared in @StockheadAU. Take a look: bit.ly/ATX-Stockhead-… #Amplia #biotech #pancreaticcancer #clinicaltrials
$ATX | #Amplia has today announced that the US FDA has cleared Amplia’s IND application for a trial of Amplia’s best-in-class FAK inhibitor narmafotinib in pancreatic cancer. Read the ASX release: bit.ly/ATX-FDA-IND #biotech #pharma #pancreaticcancer #clinicaltrial #FDA
$ATX | #Amplia has today announced it has reached another significant milestone this week, with dosing of the first patient in the Phase 2a portion of the ACCENT trial. Read the ASX release: bit.ly/ATX-First-2A-P… #biotech #pharma #pancreaticcancer #oncology #clinicaltrials
Cosmos Magazine | #Amplia CEO & MD Chris Burns recently spoke with journalist Caroline Zielinski from @ComosMagazine about the highs and lows of developing drugs in Australia. Take a look: bit.ly/Cosmos-magazine $ATX #biotech #innovation #pharma #drugdiscovery
$ATX NEWSLETTER | Our latest Investor Newsletter is now online – take a look: bit.ly/ATX-December-N… $ATX #ASX #innovation #biotech #pharma #oncology #pancreaticcancer #clinicaltrial
Excited to be visiting Seoul National University Hospital with our Clinical Operations Manager Nicole Kruger to discuss narmafotinib and the ACCENT trial in pancreatic cancer.
Amplia CEO and MD, Dr Chris Burns, is in Korea this week, finalising plans for recruitment of patients into the Phase 2b ACCENT trial in pancreatic cancer patients. $ATX #biotech #pharma #innovation #pancreaticcancer #oncology #korea linkedin.com/posts/chris-bu…
$ATX | Amplia has today announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved a clinical trial to test narmafotinib (AMP945) in advanced pancreatic cancer patients in Korea. Read today’s ASX release bit.ly/ATX-Korea-Appr… $ATX #pancreaticcancer #oncology
On #WorldPancreaticCancerDay, we reaffirm our commitment to fight pancreatic cancer. Our ACCENT study aims to revolutionise treatment for patients, for a chance for a better future. $ATX #biotech #pharma #innovation #pancreaticcancer #clinicaltrial #WPCD2023
Dimi 63 @Dimitrios_1963
10K Followers 427 Following I am a Retired person and just trying to be a nice guy here, These tweets are just my thoughts and NOT financial advice or recommendations. DYOR and DD always.
N-KaT @nkat007
3K Followers 1K Following ASX Investor / trader. Opinions are my own, not financial advice. Always DYOR.
Zynext Ventures @VenturesZy27980
22 Followers 59 Following Zynext Ventures is a 'New-age' venture capital firm investing in seed and early-stage disruptive healthcare technologies.
ARROWHEAD @arrowheadbid
446 Followers 97 Following Posting equity and market research, and a forum for company presentations. Follow us for research ideas and objective analysis.
Craig Morton @_DrCJM_
502 Followers 1K Following Scientist, father, gamer, avid reader, whisky aficionado and recreational scuba diver. All things #proteinstructure and #drugdesign 🇦🇺 #cancersucks
Sean Mackay @seanmackaynz
109 Followers 287 Following Nanomaterials, neural technology, and drug delivery scientist; Commercialisation @MasseyUni; Research Associate @Gillies_McIndoe; Advisor @humblebeebio
Dr. Aminah Alroqi @Agalotaibi2
91 Followers 826 Following Academic Researcher @KACST | PhD @ImperialMed & @ChelwestFT |Teaching Assistant @Imperiacollege #CancerResearch #Oncology #جامعات_النخبة #epigenetic حساب شخصي
Rob Frost @RobFrost73
3 Followers 6 Following
Rick🇭🇲⚡☕�.. @reekiely
113 Followers 653 Following Engineer | Tech | Money Smart | Value (Trap) Investor
Owner @Seanouthy127971
12 Followers 2K Following My world is a field full of sunflowers, where the sun shines and hope blooms.
J Smith @JSmith58394448
0 Followers 79 Following
GI Cancer Institute a.. @GICancer
2K Followers 1K Following We raise funds for clinical research which improves gastro-intestinal cancer treatment and conduct research as the Australasian Gastro-Intestinal Trials Group.
Dr Arisbel B Gondin �.. @ArisbelBGondin
821 Followers 883 Following 👩🏽🔬 Postdoc @MIPS_DDB using #sdAbs #nanobodies for GPCR structural biology & pharmacology | Views my own
ARC Centre for Fragme.. @ARC_CFBD
609 Followers 752 Following The ARC ITTC for Fragment-Based Design. Accelerating research translation.
Toby Grainger @grainger_toby
3 Followers 54 Following
Just a nobody really. @_lucrum
20 Followers 461 Following Love seeing Bio tech and medical breakthroughs. Not financial advice, and do your own research, right.
Sleebs Lab @Sleebs_Lab
521 Followers 636 Following Medicinal Chemistry and Chemical Biology Research Laboratory @WEHI_research #cancer #malaria #infectiousdiseases | views are our own
Praful @PRAFUL_2021
215 Followers 2K Following
Ben Rodney @BenRodney3
28 Followers 67 Following The best thing about stockbroking- there is never a dull day. The worst thing about stockbroking, there is never a dull day 😁
István Taisz @istvan_taisz
219 Followers 465 Following Project Manager @Turbine_ai, omics, ML, oncology former PhD student @MRC_LMB
George Collings @GeorgeCollings3
1 Followers 94 Following Mature, relaxed male interested in others regardless of race or belief.
J GW @JGW66996113
23 Followers 13 Following
Reasonably Rational @RationalistMC
117 Followers 535 Following
Syner-G BioPharma Gro.. @syner_g_bio
56 Followers 139 Following A chemistry, manufacturing, and controls solution provider that specializes in the pharmaceutical and biotech industry.
Chris Jackson, MD MS @Chris_JacksonMD
307 Followers 1K Following Childhood Cancer Survivor. PGY4 Radiation Oncology Resident at MSK. Working to make cancer treatment more powerful with fewer side effects. Views my own.
Angad Ram @ra68624178
3 Followers 31 Following Dijital skills help me students only watsapp 6386971890
Richard Morgan @Richard06457561
80 Followers 746 Following
@atomhightech
48 Followers 459 Following
Ekat Martin Herbas @EkatMartin
283 Followers 2K Following Infectious diseases specialist at the Brazzaville teaching hospital
John Saba @asxgrowthstocks
30 Followers 205 Following
James B @jamus21
114 Followers 1K Following
Cancer Research Horiz.. @CR_Horizons
2K Followers 2K Following We are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Bharat Kumar @BharatK78245994
100 Followers 214 Following Stockmarket investor/trader with interest in varied sectors/areas ... not here to provide any advice.
Enock Atukwase @EnockAtukwas19
44 Followers 308 Following
Theodora @theophilic
34 Followers 104 Following
Nick @saintnick67
53 Followers 290 Following
Gendron Recherche @gendron_gendron
617 Followers 1K Following Cancer research is basic research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure.
lebron @Kaonukaito
2 Followers 201 Following
The Sentiment @TheSentimentAu
1K Followers 1K Following Business news, opinion and satire shaping investor sentiment around the #ASX. Join our newsletter mailing list at: https://t.co/UNOpvZIFV2
Puma58 @sergioalej07
2K Followers 5K Following
Jodie Price @Jodie_Roadie
18 Followers 71 Following
Adriana Noboa @adriananoboadra
104 Followers 255 Following Radióloga especialista en PET CT / PET MAMA CON INTELIGENCIA ARTIFICIAL
Hawkins Lab @HawkinsLab4
205 Followers 231 Following Organic synthesis group at the University of Otago, Dunedin, New Zealand
HE @HEHSYDNEY
11 Followers 221 Following
Jad21 @asammakieh
110 Followers 737 Following
ARC Centre for Fragme.. @ARC_CFBD
609 Followers 752 Following The ARC ITTC for Fragment-Based Design. Accelerating research translation.
Invasion and Metastas.. @Timpson_Lab
1K Followers 405 Following Our lab uses intravital imaging approaches to pinpoint critical events that drive tumour invasion and metastasis | @GarvanInstitute @KinghornCancer @UNSW
Caitlin Dugan @CaitlinDugan
627 Followers 472 Following Freelance journalist | Ten News First Sydney @10NewsFirstSyd and ABC News Sydney @abcnews
Publer @publer
46K Followers 158 Following Your ultimate social media management platform 💚 Plan, Schedule, Collaborate, Analyse & Report Explore Publer for free: https://t.co/0HhKEaZa4Q
Brooke Pereira @brooke_pereira_
742 Followers 1K Following @GarvanInstitute Cancer Institute NSW Fellow in the @Timpson_Lab #cafs #matrix #imaging #proteomics #PDAC. Work and live on Gadigal land (she/her)
Kendelle J Murphy @KendelleJMurphy
107 Followers 63 Following Postdoc at the @GarvanInstitute with @Timpson_Lab. Pancreatic Cancer | Tumour Microenvironment | Intravital Imaging 🔬| Stromal Targeting
Claire Harvey @chmharvey
6K Followers 829 Following Hackette about town. Editorial Director, The Australian.
Elon Musk @elonmusk
182.0M Followers 588 Following
Elizabeth Fortescue @Ozartwriter
4K Followers 3K Following Australian art writer and arts journalist. My Saleroom column on the art market is in every Thursday's Australian Financial Review. Posting personal views only.
Michael Genovese @GenoveseMichael
5K Followers 4K Following Nine News. If found please call @jerriedemasi.
Small Caps 🇨🇳 (.. @SmallCaps_cn
1K Followers 1K Following Small Caps 是让中国投资者了解澳大利亚、加拿大、英国、美国和德国市场所有行业的股市新闻和小型股公司信息的第一大网站。 https://t.co/RrjHmCA69T
Small Caps 🇨🇦 @SmallCapsCanada
2K Followers 1K Following Small Caps is Canada's #1 site for stock market news and information on small cap companies listed on the TSX, TSX-V, CSE and Cboe exchanges.
Small Caps @SmallCapsASX
25K Followers 1K Following Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Newsletter: https://t.co/6Y8mZeyPwH
Nine News Sydney @9NewsSydney
593 Followers 0 Following
Andrew Scott @AndrewScottTV
6K Followers 2K Following Director, Co-Founder - JustStocks (https://t.co/agSZ2aXpGm) Non Executive Director - ECR Minerals PLC (LON:ECR)
Kara Ordway @KaraOrdway
2K Followers 5K Following
Sharnelle Vella @SharnelleVella
76K Followers 1K Following State Political Reporter @7NewsMelbourne Ambassador @lostdogshome
MTPConnect @MTPConnect_AUS
6K Followers 2K Following We are Australia's Life Sciences Innovation Accelerator championing the continuing growth of Australia's vibrant medical products sector.
Warwick Tong @ctxalum
247 Followers 183 Following Finding cures for cancer. Collaborative research working well
Haley Chartres @Hales_Chartres
445 Followers 1K Following Melbournite. Communications specialist. H^CK Director. Celebrant. Frank’s Mum - love him to bits.
Adnan Nagrial @AdnanNagrial
707 Followers 260 Following Medical Oncologist. Westmead/Blacktown Hospitals. Associate Professor, University of Sydney. Clinical Researcher. Gastrointestinal and Lung cancers.
Aatur Singhi, MD PhD @PancPathologist
7K Followers 5K Following Pancreatic/Gastrointestinal Pathologist. T/RT ≠ medical advice
Anirban Maitra @Aiims1742
28K Followers 2K Following Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Reach Markets @Reach_Markets
604 Followers 413 Following Reach Markets - Empowering investors and traders with the best tools, access to experts and opportunities. Reach Financial Group (AFSL Number 33329).
Kathy Harrison @KathyMHarrison
262 Followers 214 Following Drug developer, passionate about translation of life science to improve patients lives, loves skiing, yoga and travel.
Nick Ede @Melroseavenick
922 Followers 439 Following Imugene Ltd. Chief Technology Officer & Laser Sailor!
AdAlta Limited @AdAlta1AD
637 Followers 205 Following Targeting untreated diseases using the i-body: a unique drug discovery platform. ASX: 1AD.
Chimeric Therapeutics.. @Chimeric
1K Followers 504 Following The ASX Leader in #CellTherapy #CLTXCART #Chlorotoxin #NKCells $CHM
Damian Slizys @slizys
26 Followers 152 Following
Gabriel Liberatore @GabLiberatore
412 Followers 1K Following Group Chief Operating Officer. Non-Exec Director. Passion for working at the interface between life-changing medical science and business
BoardroomMedia @boardroom_media
3K Followers 1K Following Media production and broadcasting provider of choice for ASX listed companies, funds and professional services firms.
ASX small caps @ASX_small_caps
17K Followers 3K Following All the news about small cap stocks on the Australian Securities Exchange (ASX) - before they become big caps! NB: RTs not endorsements & do your own research.
Verastem Oncology @VerastemOncolog
3K Followers 1K Following Verastem Oncology is committed to developing and commercializing medicines to improve the lives of patients with #RAS pathway-driven #cancers. $VSTM
Canthera Discovery @cantheradiscov
629 Followers 259 Following Dedicated to finding cures for cancer. A small molecule, oncology focused, drug discovery organisation that partners with leading Australian research institutes
Galapagos @GalapagosGlobal
4K Followers 457 Following 🌐 Global Twitter account | We aim to transform patient outcomes through life-changing science and innovation for more years of life and quality of life
EU-PFF @EU_IPFF
3K Followers 906 Following The European Pulmonary Fibrosis Federation (EU-PFF) is a European Federation of national #IPF & #PF/#Pulmonaryfibrosis patient associations.
PF Warrior @IPFWarrior
3K Followers 5K Following PF Warriors is an international support network that provides education, inspiration, & hope to those with pulmonary fibrosis. Patients helping patients!
Pulmonary Fibrosis Fo.. @PFFORG
7K Followers 1K Following We imagine a world without pulmonary fibrosis. https://t.co/e5cmq67fNV
Pulmonary Fibrosis Ne.. @pulmonaryfibros
2K Followers 260 Following We exist to bring you science, research and clinical news about PF. We are a free digital publication dedicated to the patient community.
Idiopathic pulmonary .. @IpfRm
1K Followers 170 Following Helping you better understand, manage and talk about idiopathic pulmonary fibrosis (IPF). Join us at https://t.co/gSi1wts8u6
Pancreatic Cancer UK @PancreaticCanUK
24K Followers 6K Following Together we’ll transform the future of pancreatic cancer. Registered charity in England, Wales & Scotland.
Pancreatic Cancer EU @PCE_Association
1K Followers 279 Following PCE – Pancreatic Cancer Europe is a European multi-stakeholder platform, created to raise awareness of pancreatic cancer and achieve earlier diagnosis
Patrys @PatrysLtd
639 Followers 137 Following Developing novel antibody technologies for hard-to-treat cancers | ASX:PAB | Tag or follow us at $PAB.
Toby Maher @TobyMMaher
3K Followers 529 Following Director of ILD @KeckMedUSC. @asthmalunguk Prof of Respiratory Research, @imperialNHLI Prof of Interstitial Lung Disease and #IPF doctor. Working to #cureIPF
Axel Grothey @agrothey
3K Followers 526 Following Passionate about justice & tolerance, teaching & educating oncologists, caring for cancer patients, learning from mistakes. Opinions and statements are my own.
SeerPharma QA & GMP @SeerPharma_GMP
154 Followers 57 Following Advancing Quality and GMP Best-Practices in the APAC Region for Pharmaceuticals and Medical Devices: Consulting | Training | MasterControl | Contracting
Stuart Roberts @Biotech_Buzz
739 Followers 125 Following Providing independent research coverage of ASX companies (general advice) through NDF Research and Pitt Street Research. Nisi Dominus Frustra.
Happy third birthday to my adorable niece whose entrance into this world is something I will never forget… 🎂🫣🫠
Got the middle of the night call that I’d been waiting for! My sister in law was in labour and I was the drop everything babysitter for my 2yo niece. As soon as I arrive at their place, my brother says um things have gotten intense very quickly...
We are thrilled to announce three of our researchers received a MBSANZ award! Congratulations to A/Prof Thomas Cox for receiving the Barry Preston Award, Dr Kendelle Murphy for receiving the Bob Fraser Award and Ellie Mok for receiving the Dennis Lowther Award.
Final session of the day. Chris Burns from @ampliatx taking about their success story.
We were excited to have Prof. Andrew Wilks and Dr. Chris Burns join our Melbourne office last night to speak about the recent FDA approval for their drug Ojjaara (momelotinib); a breakthrough medication designed for adults with anaemia. Thanks to everyone who joined us!
We're delighted to share that Professor Brett Sutton has been appointed our new Director of Health and Biosecurity. Brett joins us from his current role as @VictorianCHO where he has provided expert advice on the health and wellbeing of Victorians. More: csiro.au/en/news/All/Ne…
LAUNCHED: For the first time in 20 years, Australia's biotech sector has united to launch the #BiotechnologyBlueprint: A Decadal Strategy for the Australian Biotechnology Industry - a shared industry vision &‘blueprint’ navigating the biotech ecosystem... ausbiotech.org/news/industry-…
Amplia Therapeutics (#ASX: $ATX) confirms anti-cancer drug AMP945 can inhibit focal adhesion kinase in healthy volunteers smallcaps.com.au/amplia-therape… @ampliatx
Prof Paul Timpson and his team have discovered a new approach to ‘prime’ pancreatic cancers before chemotherapy, which may be a more effective way to treat the cancer in patients. ow.ly/aRef50Gj6h4 @Timpson_Lab
Amplia Therapeutics说，“启动”肿瘤可以改善胰腺癌患者的预后 smallcaps.com.au/amplia-therape… #ASX $ATX @ampliatx
.@ampliatx : @GarvanInstitute Backs FAK For #PancreaticCancer - subscribe to Biotech Daily biotechdaily.com.au
The Hon John Brumby AO is the Chair of the @breakthroughvic Fund. Ahead of his keynote address at Bio Connections Australia, he shared insights on the future of Australian biotechnology and the impact the Breakthrough Victoria Fund is having. MORE: ow.ly/Oeie50GcwLS
INDUSTRY NEWS | Big pharma has just invested $45M in a new start-up targeting fibroblasts – endorsing how #Amplia is using its FAK inhibitors to treat #cancer by modifying tissues surrounding tumours like pancreatic cancer 👉 bit.ly/ATX_FierceBio $ATX @FierceBiotech
.@ampliatx : AMP945 Improves #PancreaticCancer Chemo, In #Mice - subscribe to Biotech Daily biotechdaily.com.au
$ATX | New data from our collaboration with Prof Paul Timpson of the @GarvanInstitute shows that adding AMP945 to gemcitabine/Abraxane® was shown to increase survival by 27% in mice. Read more on the #ASX: bit.ly/ATX_GarvanData #Amplia #cancertherapeutics #biotech #innovation
Congratulations to our collaborator and adviser, Professor Mark Dawson for receiving this award.
Congratulations to Professor Mark Dawson from the Peter MacCallum Cancer Centre, recipient of the 2020 Frank Fenner Prize for #LifeScientist of the Year. Fantastic! 🔬 Read more: bit.ly/2Tw645K Watch live: industry.gov.au/pmscienceprizes #pmprizes
Gain exclusive insights into some of Australia’s most innovative & rapidly growing industries as we're joined by 3 exciting #ASX-listed companies. Register: hubs.ly/H0xXL8t0 TALi Digital $TD1 #technology @tesserent $TNT #cybersecurity @ampliatx $ATX #biotech
$ATX FEATURE | Together with @cancercrc and @CancerAustralia, #ampliatherapeutics is headlining today's @australian in a moving story about nurturing our medical research ecosystem to conquer #cancer. Thanks to @NC_Robinson for sharing our journey 👉bit.ly/ATX_TheAustral…
$TLX is excited to announce our live session at #EANM2020 satellite symposium... "Next Generation Imaging with PSMA-PET & More", will be held on 29th Oct 2020 at 13:30 (CET) Visit our website to learn more: ow.ly/qGbC50BNU1k #SeeItTreatIt #Theranostics #EANM20Virtual
We are excited to announce a drug developed by our scientists has entered phase 1 trials in Melbourne. Read more about this discovery in today's @australian Newspaper #madeinmelbourne #cancer #clinicaltrials #cancerresearch theaustralian.com.au/science/austra…
Trends for United States
You might like
